1 insiders reported 1 Form 4 transactions for Raphael Pharmaceutical Inc. (RAPH) over the past 18 months (most recent 2026-04-06). Recent activity: Louria Hayon Igal (Chief Technology Officer) Buy 350,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-06 | Louria Hayon Igal | Chief Technology Officer | Buy | 350,000 | $3,500 |
来源：SEC Form 4 申报文件 · 截至 2026-04-06